Obesity – HOME

Eli Lilly’s GLP-1 Dominance: Beyond the Blockbuster Numbers

Eli Lilly’s blockbuster quarter with Zepbound and Mounjaro signals more than just financial success. The pharmaceutical giant faces critical challenges in scaling production and defending market share against intensifying competition.

by Darren HoltOctober 30, 2025November 2, 2025

Business Innovation Technology

Wall Street’s AI and Earnings Focus Intensifies Ahead of Tech Reports

Wall Street analysts are positioning ahead of major tech earnings with intensified focus on AI infrastructure demand and strategic shifts. Key calls cover Apple’s iPhone cycle, Microsoft’s capacity constraints, and Reddit’s growth initiatives.

by Darren HoltOctober 28, 2025November 2, 2025